$23.80
0.692.99%
In chiusura: -
$23.80
0.000.00%
After hour: Oct 3, 4:00 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Apellis Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 4
Stima EPS
$0.780
Stima dei ricavi trimestrali
$358.02M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$754.65M
Analizza lo storico degli utili di Apellis Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals | -$0.46 | $0.78 | — | — | $196.83M | $358.02M | — | — | 11/04/2025 | |
APLS | Apellis Pharmaceuticals | -$0.30 | -$0.46 | -$0.33 | 28.26% | $199.69M | $188.42M | $178.49M | -5.27% | 07/31/2025 | |
APLS | Apellis Pharmaceuticals | -$0.54 | -$0.34 | -$0.74 | -117.65% | $172.32M | $197.60M | $166.80M | -15.59% | 05/07/2025 | |
APLS | Apellis Pharmaceuticals | -$0.73 | -$0.40 | -$0.29 | 27.50% | $146.38M | $197.91M | $212.53M | 7.39% | 02/28/2025 | |
APLS | Apellis Pharmaceuticals | -$1.17 | -$0.30 | -$0.46 | -53.33% | $110.40M | $200.35M | $196.83M | -1.76% | 11/05/2024 | |
APLS | Apellis Pharmaceuticals | -$1.02 | -$0.32 | -$0.28 | 12.50% | $94.97M | $193.78M | $199.69M | 3.05% | 08/01/2024 | |
APLS | Apellis Pharmaceuticals | -$1.56 | -$0.52 | -$0.54 | -3.85% | $44.85M | $163.35M | $172.32M | 5.49% | 05/07/2024 | |
APLS | Apellis Pharmaceuticals | -$1.50 | -$0.69 | -$0.73 | -5.80% | $22.66M | $143.59M | $146.38M | 1.94% | 02/27/2024 | |
APLS | Apellis Pharmaceuticals | -$1.75 | -$0.85 | -$1.17 | -37.65% | $22.06M | $99.74M | $110.40M | 10.69% | 11/01/2023 | |
APLS | Apellis Pharmaceuticals | -$1.46 | -$1.32 | -$1.02 | 22.73% | $16.32M | $70.25M | $94.97M | 35.19% | 07/31/2023 | |
APLS | Apellis Pharmaceuticals | -$1.42 | -$1.46 | -$1.56 | -6.85% | $14.38M | $26.10M | $44.85M | 71.82% | 05/04/2023 | |
APLS | Apellis Pharmaceuticals | -$1.61 | -$1.57 | -$1.50 | 4.46% | $60.29M | $24.19M | $22.66M | -6.31% | 02/21/2023 | |
APLS | Apellis Pharmaceuticals | -$1.57 | -$1.45 | -$1.75 | -20.69% | $5.65M | $21.59M | $22.06M | 2.16% | 11/07/2022 | |
APLS | Apellis Pharmaceuticals | -$2.72 | -$1.36 | -$1.46 | -7.35% | $623.00K | $16.94M | $16.32M | -3.65% | 08/08/2022 | |
APLS | Apellis Pharmaceuticals | -$2.32 | -$1.32 | -$1.42 | -7.58% | $0.00 | $12.57M | $14.38M | 14.41% | 05/04/2022 | |
APLS | Apellis Pharmaceuticals | $0.93 | -$1.54 | -$1.61 | -4.55% | $250.00M | $8.78M | $60.29M | 586.67% | 02/28/2022 | |
APLS | Apellis Pharmaceuticals | -$1.79 | -$1.75 | -$1.57 | 10.29% | $646.00K | $7.22M | $5.65M | -21.75% | 11/08/2021 | |
APLS | Apellis Pharmaceuticals | -$1.57 | -$1.70 | -$2.72 | -60.00% | $0.00 | $810.00K | $623.00K | -23.09% | 08/09/2021 | |
APLS | Apellis Pharmaceuticals | -$2.29 | -$1.62 | -$2.32 | -43.21% | $0.00 | $2.27M | $0.00 | -100.00% | 04/28/2021 | |
APLS | Apellis Pharmaceuticals | -$1.77 | — | $0.93 | — | $0.00 | $96.09M | $250.00M | 160.17% | 02/25/2021 | |
APLS | Apellis Pharmaceuticals | -$1.09 | — | -$1.79 | — | $0.00 | — | $646.00K | — | 11/02/2020 |
Apellis Pharmaceuticals (APLS) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $-0.33 | $-0.46 | 28.3 % |
| Q1 | 2025-05-07 | $-0.74 | $-0.34 | -117.7 % |
| Q4 | 2025-02-28 | $-0.29 | $-0.40 | 27.5 % |
| Q3 | 2024-11-05 | $-0.46 | $-0.30 | -53.3 % |
Apellis Pharmaceuticals (APLS) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $178.49M | $188.42M | -5.27 % |
| Q1 | 2025-05-07 | $166.80M | $197.60M | -15.6 % |
| Q4 | 2025-02-28 | $212.53M | $197.91M | 7.39 % |
| Q3 | 2024-11-05 | $196.83M | $200.35M | -1.76 % |
FAQ
Quando Apellis Pharmaceuticals (NASDAQ:APLS) riporterà gli utili?
Si prevede che Apellis Pharmaceuticals (APLS) fornisca risultati il novembre 4, 2025. Gli ultimi risultati sono stati pubblicati il luglio 31, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Apellis Pharmaceuticals (NASDAQ:APLS)?
L'EPS effettivo era $-0.33, che superato la stima di $-0.46.
Quali sono state le entrate di Apellis Pharmaceuticals (NASDAQ:APLS)?
Le entrate effettive sono state $178.5M, che mancato la stima di $188.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.